blueshirt 22

[blueshirt 22 @TomIsett]

@MaxBlumenthal Z

[blueshirt 22 @TomIsett]

@CathyJoeGPT @lrozen Why? Don’t you understand the financial/access incentives? Operation Mockingbird? Lots of systemic structures support the exhibited behavior.

[blueshirt 22 @TomIsett]

@TrumpWarRoom @RepLuna Don’t care about yawner Filipino deal, do care about Epstein. Existential threat to our country

[blueshirt 22 @TomIsett]

@HealthRanger Yeah, but he now sucks. We want to know who runs the blackmail ring and the West’s governments.

[blueshirt 22 @TomIsett]

@TFL1728 @NakedHedgie Why is that the “one question”? I’m a huge fan of yours, but why wasn’t the Epstein case the moment to break-the-cycle?

[blueshirt 22 @TomIsett]

@35quai Btw, wondering about the soft talking in the background of your vids…Is it to soothe the consumer or throw off AI or something else?

[blueshirt 22 @TomIsett]

@35quai Not sure how I found you on YouTube, but with your recent coffee report, I now found you here. Which gives the oppt’y to say Thank You!

[blueshirt 22 @TomIsett]

@frankoz95967943 3m, Kpmg, et al as sponsors. Please explain

[blueshirt 22 @TomIsett]

Scientists say clinical trials for ‘variant-proof’ vaccines could start very soon https://t.co/pFQqmuIzQv: E or M proteins could be part of the solution, but agree that nucleocapsid [N] + spike [S] has the most promise for next-gen vaccines

[blueshirt 22 @TomIsett]

The Special Sauce That Makes Some Vaccines Work https://t.co/EAO1nQEwB1

[Steve Clemons @SCClemons]

Look forward to discussing what’s possible in massive plant-based #vaccine manufacturing and its two vaccine candidates with #iBio CEO Tom Isett on today’s #coronavirus report from @thehill. #COVID19 #innovation https://t.co/dj4RfVeE3V

[Dr. Jan Nolta @jan_nolta]

My contribution to #FunFactFriday - human Mesenchymal #StemCells from bone marrow share material from inside themselves (protein, RNA) with damaged target cells through microparticles, exosomes, and tunneling nanotubules. It's called Cell-to-Cell communication. We love science!

[blueshirt 22 @TomIsett]

Risky, given companies like Poseida are working allogeneic CAR-T alternatives for same indication https://t.co/2f46bHZiAR

[William Elliott @cells_nnm]

Michael Kalos (Jassen) - J&J is planning to build wholly owned centralized CAR-T manufacturing plants around the world, following $NVS and $GILD model https://t.co/5AhBzt3DWD

[blueshirt 22 @TomIsett]

https://t.co/TcyZm811IL https://t.co/POP6Lbayvr

[blueshirt 22 @TomIsett]

Florida gene therapy manufacturer to move HQ to Lexington, hire 200 https://t.co/6V6Z9It3a5 via @BosBizJournal

[blueshirt 22 @TomIsett]

Go REGROW, and keep the USA competitive in cellular therapeutics! https://t.co/jAxEpVYFNi

[Mike Coffman @RepMikeCoffman]

.@BPC_Bipartisan - thanks for supporting the REGROW Act! https://t.co/g3A4sguDPu

[blueshirt 22 @TomIsett]

More good news for cell therapy innovation. @vanekland and @MichaelMay5 making it happen! https://t.co/vpPmXqi4Dm

[blueshirt 22 @TomIsett]

I just donated to @Wikipedia. Help keep it free! #keepitfree https://t.co/aEFXsfXfL4

[blueshirt 22 @TomIsett]

Commence Bio to Present at 2015 Stem Cell Meeting on the Mesa http://t.co/FVKr5srG98

[blueshirt 22 @TomIsett]

Synthetic biology development w/some interesting utility?: http://t.co/mTntLPS7MN via @physorg_com. @ACSSynBio